33.68
6.62%
2.09
Handel nachbörslich:
33.68
Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten
Sanara MedTech (NASDAQ:SMTI) Is Carrying A Fair Bit Of Debt - Simply Wall St
Long Term Trading Analysis for (SMTI) - Stock Traders Daily
Sanara MedTech (NASDAQ:SMTI) Furnishes Investor Presentation for Piper Sandler 36th Annual Healthcare Conference - Defense World
Sanara MedTech to Present at Healthcare Conference - TipRanks
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th - GlobeNewswire
Sanara MedTech to Present at Piper Sandler Healthcare Conference in December | SMTI Stock News - StockTitan
All You Need to Know About Sanara MedTech (SMTI) Rating Upgrade to Buy - MSN
Sanara MedTech Inc. (NASDAQ:SMTI) Shares Sold by Janney Montgomery Scott LLC - MarketBeat
US$44.00: That's What Analysts Think Sanara MedTech Inc. (NASDAQ:SMTI) Is Worth After Its Latest Results - Simply Wall St
Sanara MedTech Inc. (NASDAQ:SMTI) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
(SMTI) Investment Report - Stock Traders Daily
Earnings call: Sanara MedTech posts 35% revenue increase in Q3 - Investing.com India
Sanara MedTech Inc. (NASDAQ:SMTI) Q3 2024 Earnings Call Transcript - Insider Monkey
Sanara MedTech Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Sanara MedTech Inc (SMTI) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
Sanara MedTech Reports Strong Revenue Growth Amid Challenges - TipRanks
Sanara MedTech’s net revenue increases 35% in Q3 2024 - Medical Buyer
Sanara Medtech earnings beat by $0.28, revenue topped estimates - Investing.com Canada
Sanara MedTech Inc (SMTI) Q3 2024 Earnings: Revenue Surpasses Es - GuruFocus.com
Sanara MedTech Inc. Reports Third Quarter 2024 Results - The Manila Times
Sanara MedTech Reports 35% Revenue Surge to $21.7M, Marks 12th Straight Record Quarter | SMTI Stock News - StockTitan
Sanara MedTech Inc (SMTI) Q3 2024: Everything You Need To Know A - GuruFocus.com
Sanara MedTech (SMTI) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
(SMTI) Investment Analysis and Advice - Stock Traders Daily
Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Shares Up 1.5% – What’s Next? - Defense World
Sanara MedTech (NASDAQ:SMTI) Shares Up 1.5%Should You Buy? - MarketBeat
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates - GlobeNewswire
(SMTI) Investment Analysis - Stock Traders Daily
Retail investors who hold 32% of Sanara MedTech Inc. (NASDAQ:SMTI) gained 12%, insiders profited as well - Simply Wall St
Keith Myers named Sanara MedTech director - Medical Buyer
Sanara MedTech reshuffles board with new director - Investing.com
Sanara MedTech Board Evolution with Strategic New Appointment - TipRanks
Sanara MedTech Appoints Keith Myers to Board - citybiz
Sanara MedTech Inc. Announces Changes to Its Board of Directors - GlobeNewswire
InfuSystem, Sanara MedTech Partner For Distribution Deal - MPO-mag
InfuSystem, Sanara MedTech Partner for Distribution Deal - MPO-mag
(SMTI) On The My Stocks Page - Stock Traders Daily
Sanara MedTech (NASDAQ:SMTI) Trading Down 4.1% - Defense World
Analyzing Sanara MedTech (NASDAQ:SMTI) and Nutriband (NASDAQ:NTRB) - Defense World
Sanara MedTech Inc (SMTI) Shares Up 5.03% on Sep 27 - GuruFocus.com
Fort Worth health care company reaches compensation deal with new CEO - The Business Journals
Wound Cleanser Product Market to Surpass US$ 2.24 Billion, Expanding at a 1.4% CAGR by 2034: Fact.MR - GlobeNewswire Inc.
Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years - Yahoo Finance
Sanara MedTech Inc. signs CEO Nixon to new employment terms - Investing.com India
Sanara MedTech Appoints Ronald T. Nixon as CEO with Incentive-Based Pay - TipRanks
Financial Analysis: Sanara MedTech (NASDAQ:SMTI) vs. Bone Biologics (NASDAQ:BBLG) - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):